Page last updated: 2024-08-21

cyclopentane and Cardiac Hypertrophy

cyclopentane has been researched along with Cardiac Hypertrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aiello, EA; Blanco, PG; Di Mattia, RA; Jaquenod De Giusti, C; MariƔngelo, JIE; MundiƱa-Weilenmann, C; Orlowski, A; Portiansky, EL1
Chappell, MC; Groban, L; Jessup, JA; Lindsey, SH; Wang, H1

Other Studies

2 other study(ies) available for cyclopentane and Cardiac Hypertrophy

ArticleYear
The activation of the G protein-coupled estrogen receptor (GPER) prevents and regresses cardiac hypertrophy.
    Life sciences, 2020, Feb-01, Volume: 242

    Topics: Animals; Animals, Newborn; Blotting, Western; Cardiomegaly; Cells, Cultured; Cyclopentanes; Echocardiography; Eplerenone; Male; Myocytes, Cardiac; Quinolines; Rats; Rats, Inbred SHR; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, G-Protein-Coupled

2020
Attenuation of salt-induced cardiac remodeling and diastolic dysfunction by the GPER agonist G-1 in female mRen2.Lewis rats.
    PloS one, 2010, Nov-03, Volume: 5, Issue:11

    Topics: Animals; Blood Pressure; Cardiomegaly; Cyclopentanes; Diastole; Echocardiography; Female; Heart; Hypertension; Immunohistochemistry; Mice; Myocardium; Quinolines; Rats; Rats, Inbred Lew; Rats, Transgenic; Receptors, G-Protein-Coupled; Renin; Reverse Transcriptase Polymerase Chain Reaction; Sodium Chloride, Dietary

2010